The term "OPR13 Antibody" does not appear in any of the provided sources, including:
Antibody characterization initiatives (e.g., YCharOS, OGA) ( ).
Commercial antibody databases (e.g., Sigma-Aldrich’s Anti-OR13A1 antibody) ( ).
The closest match is OR13A1, an olfactory receptor family member targeted by a commercial antibody ( ):
Product: Anti-OR13A1 antibody (Human Protein Atlas project).
Reactivity: Human-specific.
Applications: Immunohistochemistry (1:50–1:200 dilution) and immunofluorescence.
Immunogen: Synthetic peptide sequence YAYISPVSGYSAGKSKLAGL.
Validation: Tested against 44 normal human tissues and 20 cancer tissues.
OPR13 may refer to a hypothetical or obsolete designation not cataloged in current databases.
Potential typographical errors (e.g., "OPR" vs. "OR" for olfactory receptors).
The lack of data underscores broader issues in antibody validation:
Reproducibility: Studies show ~50–75% of commercial antibodies fail validation in standardized assays ( ).
Recombinant Antibody Superiority: Engineered antibodies (e.g., Fc-modified variants) often outperform traditional monoclonals in specificity and renewable production ( ).
If "OPR13" is critical to your work:
Verify Nomenclature: Cross-check gene/protein databases (e.g., UniProt, NCBI) for alternate names.
Explore Orthologs: Investigate homologous proteins in model organisms.
Custom Antibody Development: Consider recombinant antibody engineering for novel targets ( ).
KEGG: osa:107277381
STRING: 39947.13113.m00210
OPR13 antibody is a research reagent designed to specifically bind to the Putative 12-oxophytodienoate reductase 13 protein from rice (Oryza sativa subsp. japonica). This polyclonal antibody is typically generated in rabbits and purified using antigen-affinity methods .
Primary applications include:
Western Blot (WB) analysis for protein detection and quantification
Enzyme-Linked Immunosorbent Assay (ELISA) for sensitive antigen detection
Immunoprecipitation studies to isolate OPR13 from complex protein mixtures
When designing experiments with OPR13 antibody, researchers should consider the following methodology:
Start with optimization experiments using positive controls
Establish appropriate blocking conditions to minimize background
Determine optimal antibody dilution (typically starting with 1:1000 for WB and 1:500 for ELISA)
Include proper negative controls (secondary antibody only, pre-immune serum)
Antibody specificity is a critical consideration in research. For OPR13 antibody validation, implement the following methodological approach:
Compare multiple antibody sources: Test antibodies from different suppliers or production batches to confirm consistent binding profiles .
Perform epitope mapping: Identify the specific region(s) of OPR13 recognized by the antibody using peptide arrays or deletion mutants.
Cross-reactivity testing: Assess potential cross-reactivity with other OPR family members, particularly OPR9, which shares sequence similarity .
Knockout/knockdown validation: Use OPR13 knockout/knockdown samples as negative controls to confirm antibody specificity.
| Validation Method | Technical Approach | Expected Outcome for Specific Antibody |
|---|---|---|
| Western blot | Run purified OPR13 alongside cell lysates | Single band at expected molecular weight |
| Immunoprecipitation | Pull-down followed by mass spectrometry | OPR13 as primary identified protein |
| Cross-reactivity testing | Test against OPR9 and other family members | Minimal binding to related proteins |
| Signal reduction test | Compare signal in normal vs. OPR13-depleted samples | Significant signal reduction in depleted samples |
Proper storage is essential for maintaining antibody functionality. For OPR13 antibodies:
Short-term storage (up to 1 month): Store at 4°C with preservatives (typically 0.02% sodium azide).
Long-term storage: Aliquot and store at -20°C or -80°C to avoid freeze-thaw cycles, which can degrade antibody performance.
Working dilutions: Prepare fresh on the day of use, or store at 4°C for no more than 1 week.
Stability assessments: Periodically test antibody performance against reference standards to monitor potential degradation over time.
A systematic approach to antibody storage validation includes testing activity after different storage conditions and time periods, and documenting the results to establish optimal protocols for your specific research applications.
The efficacy of OPR13 antibody in plant tissue is significantly influenced by antigen expression levels and turnover rates. Mathematical models of antibody transport predict that these factors are critical determinants of penetration .
When working with plant tissues expressing OPR13:
Consider fixation methods: Different fixation protocols affect epitope accessibility. For OPR13 detection in rice tissues, compare cross-linking fixatives (paraformaldehyde) with precipitating fixatives (acetone) to determine optimal preservation of antigen recognition.
Tissue penetration strategies: For thicker sections or whole-mount preparations, implement extended incubation times (24-48 hours) at 4°C and include detergents (0.1-0.3% Triton X-100) to enhance antibody penetration.
Antigen retrieval optimization: Test multiple antigen retrieval methods (heat-induced, enzymatic, pH-based) to maximize epitope exposure without causing tissue damage.
Research demonstrates that antibody penetration is inversely related to antigen expression level and turnover rate, with mathematical models suggesting that targets with lower expression and slower internalization rates allow for better tissue penetration . When designing immunohistochemistry experiments with OPR13 antibody, consider these parameters and adjust protocols accordingly.
Distinguishing between closely related proteins like OPR13 and OPR9 presents significant challenges. Recent research in antibody engineering and selection provides innovative approaches:
Biophysics-informed modeling approach: Recent advances utilize phage display experiments to select antibodies against combinations of closely related ligands. This approach associates each potential ligand with a distinct binding mode and enables prediction and generation of specific variants beyond those observed in experiments .
Disentangling multiple binding modes: When OPR13 and OPR9 share epitopes, computational analysis can identify different binding modes associated with particular ligands, even when these epitopes are chemically very similar .
Custom specificity profile design: Create antibody variants with predefined binding profiles, either cross-specific (interacting with several distinct ligands) or highly specific (interacting with a single ligand while excluding others) .
For experimental validation of specificity:
| Approach | Methodology | Application to OPR13/OPR9 Discrimination |
|---|---|---|
| Competitive binding assays | Pre-incubate antibody with purified OPR9 before OPR13 detection | Reduction in signal indicates cross-reactivity |
| Epitope mapping | Identify unique vs. shared epitopes between OPR13 and OPR9 | Target antibody production to unique regions |
| Affinity measurements | Surface Plasmon Resonance to determine binding constants | Select antibodies with >10× higher affinity for OPR13 |
| Computational design | Model-guided antibody engineering | Generate variants with customized specificity profiles |
Combination approaches using multiple antibodies can significantly improve detection parameters. Research on antibody combinations demonstrates enhanced efficacy compared to single antibody applications .
Methodological approach:
Epitope mapping combinations: Select antibodies that target different epitopes on OPR13 to increase avidity and reduce the probability of false negatives due to epitope masking or modification.
Sandwich ELISA optimization: When one antibody is used for capture and another for detection, systematically test different antibody pairs to identify combinations that maximize signal-to-noise ratio.
Signal amplification strategies: Implement systems such as:
Biotin-streptavidin enhancement
Tyramide signal amplification
Polymer-based detection systems
Validation across multiple detection platforms: Test antibody combinations across different applications (WB, ELISA, IHC) to ensure consistent performance.
Research data suggests that combining two high-affinity antibodies can achieve sensitivity improvements of 10-100 fold compared to individual antibodies, while simultaneously reducing background and cross-reactivity issues .
Quantitative analysis using OPR13 antibodies requires careful experimental design and standardization:
Reference standard development: Generate purified recombinant OPR13 at >85% purity as determined by SDS-PAGE to create calibration curves.
Internal loading controls: Select appropriate housekeeping proteins that maintain stable expression across different rice varieties.
Normalization strategies: Implement multiple normalization approaches:
Total protein normalization (Ponceau S, SYPRO Ruby)
Housekeeping protein normalization (actin, tubulin)
Spike-in controls for absolute quantification
Technical validation: Assess technical parameters including:
Linear dynamic range determination
Limit of detection/quantification
Inter-assay and intra-assay variability
Recovery rates in complex matrices
| Analytical Parameter | Recommended Method | Expected Performance Metrics |
|---|---|---|
| Linear dynamic range | Serial dilution series | At least 2 orders of magnitude |
| Limit of detection | Signal-to-noise ratio >3:1 | Typically 0.1-1 ng/mL for ELISA |
| Reproducibility | Coefficient of variation (CV) | CV <15% for intra-assay, <20% for inter-assay |
| Recovery | Spike-in of known amounts | 80-120% recovery |
High background is a frequent challenge in antibody-based experiments. For OPR13 antibody applications, consider these methodological solutions:
Blocking optimization: Systematically test different blocking agents (BSA, casein, non-fat dry milk, commercial blocking buffers) at various concentrations (1-5%) to identify optimal conditions.
Cross-reactivity reduction: Pre-adsorb antibodies with plant extracts lacking OPR13 to remove antibodies that bind to common plant epitopes.
Secondary antibody selection: Choose secondary antibodies with minimal cross-reactivity to plant proteins and pre-test through negative controls.
Sample preparation refinement: Implement additional purification steps to remove interfering compounds:
TCA/acetone precipitation for removing phenolic compounds
PVPP treatment to remove polyphenols
Protein fractionation to enrich for OPR13
Most background issues stem from non-specific binding or cross-reactivity. By systematically optimizing each protocol step and including appropriate controls, researchers can achieve optimal signal-to-noise ratios.
Epitope masking can significantly impact antibody recognition of OPR13 in complex samples. Address this challenge through:
Multiple extraction methods comparison: Test different protein extraction buffers that vary in:
Detergent type and concentration (RIPA, NP-40, Triton X-100)
Denaturing agents (urea, SDS)
Salt concentration
pH conditions
Antigen retrieval matrix: For fixed tissues, systematically test combinations of:
Heat-induced epitope retrieval at different temperatures (80-120°C)
pH ranges (citrate pH 6.0, EDTA pH 8.0, Tris pH 9.0)
Incubation times (10-30 minutes)
Enzymatic treatments: Apply proteolytic enzymes (proteinase K, trypsin) at carefully optimized concentrations and incubation times to expose hidden epitopes.
Alternative antibody formats: Test F(ab) fragments or single-chain variable fragments that may access epitopes better due to smaller size.
Systematic documentation of these optimization efforts will establish reliable protocols for consistent OPR13 detection across different experimental conditions.
OPR13's role in jasmonate biosynthesis makes protein interaction studies particularly valuable. Implement these methodological approaches:
Co-immunoprecipitation (Co-IP) optimization:
Use gentle lysis buffers to preserve protein complexes
Compare different antibody immobilization strategies (direct coupling, Protein A/G)
Include appropriate controls (IgG control, reverse Co-IP)
Validate interactions through reciprocal pull-downs
Proximity ligation assay (PLA) implementation:
Optimize fixation conditions to preserve protein complexes while maintaining epitope accessibility
Determine optimal antibody dilutions through titration experiments
Include specificity controls (single antibody controls, competing peptides)
Bimolecular Fluorescence Complementation (BiFC):
Design fusion constructs that maintain OPR13 functionality
Validate expression and localization of fusion proteins
Include appropriate negative controls (non-interacting protein pairs)
| Interaction Method | Key Advantages | Technical Considerations |
|---|---|---|
| Co-IP | Detects native complexes | Requires optimization of buffer conditions |
| PLA | High sensitivity for in situ detection | Requires two antibodies against different proteins |
| BiFC | Direct visualization in living cells | Potential for artifacts due to overexpression |
| FRET/FLIM | Can measure interaction dynamics | Requires specialized equipment and expertise |
Stress-induced changes in protein expression, modification, and localization require careful experimental design:
Standardized stress application protocols:
Define precise parameters for each stress condition (duration, intensity)
Implement consistent growth conditions before stress application
Include appropriate recovery time points
Sampling strategy optimization:
Establish time-course experiments covering early, intermediate, and late responses
Consider tissue-specific responses (roots, leaves, reproductive tissues)
Implement consistent harvesting protocols to minimize variability
Multi-level analysis approach:
Combine protein abundance measurements (Western blot, ELISA)
Assess post-translational modifications (phosphorylation, ubiquitination)
Determine subcellular localization changes (fractionation, immunolocalization)
Statistical design considerations:
Determine appropriate sample sizes through power analysis
Implement randomization strategies to minimize systematic errors
Include biological and technical replicates
By systematically addressing these considerations, researchers can generate reliable comparative data on OPR13 dynamics across different stress conditions, providing insights into jasmonate signaling pathway regulation.
Recent advances in antibody technology offer promising approaches for OPR13 research:
Biophysics-informed modeling: This approach enables the design of antibodies with customized specificity profiles, including either specific high affinity for OPR13 or cross-specificity for multiple OPR family members .
Half-life extension modifications: Techniques similar to those used in therapeutic antibodies (C135-LS and C144-LS) could create research antibodies with extended stability for long-term experiments .
Single-domain antibodies (nanobodies): These smaller antibody fragments may offer superior tissue penetration for complex plant samples, addressing limitations identified in mathematical models of antibody transport .
Recombinant antibody fragments: Expressing just the variable domains or single-chain variable fragments could improve epitope access in densely packed plant tissues.
Future research directions should explore how these emerging technologies can be applied to create next-generation OPR13 antibodies with enhanced specificity, sensitivity, and application versatility.
Emerging methodologies hold promise for enhancing OPR13 quantification:
Mass spectrometry-based approaches:
Targeted proteomics using selected reaction monitoring (SRM)
Development of isotopically labeled standard peptides for absolute quantification
Data-independent acquisition methods for improved reproducibility
Digital ELISA technologies:
Single-molecule array (Simoa) technology for ultra-sensitive detection
Adaptation of proximity extension assays for plant protein research
Microfluidic-based digital immunoassays for higher throughput
Integrated multi-omics approaches:
Correlating protein abundance with transcript levels
Integrating metabolomics data on jasmonate pathway intermediates
Combining with phosphoproteomics for functional activity assessment
| Emerging Technology | Potential Advantage | Current Limitations |
|---|---|---|
| Targeted proteomics | Absolute quantification | Requires specialized equipment |
| Digital ELISA | Ultra-high sensitivity | Limited commercial availability for plant research |
| Single-cell proteomics | Cell-type specific analysis | Technical challenges in plant cell isolation |
| Spatial proteomics | Tissue localization context | Method development needed for plant tissues |
By adopting these methodological advances, researchers can achieve more precise quantification of OPR13 in complex plant samples, enabling deeper insights into its role in jasmonate signaling and plant stress responses.